Braeburn
Ted Buckley, Ph.D. has been engaged in policy development and government relations for over 15 years. At Braeburn Ted heads up Government Affairs and Public Policy. Prior to joining Braeburn, Ted led Global Policy at Shire Pharmaceuticals after previously leading its US Government Relations and Public Policy team. While at the Shire he engaged in issues ranging from regulations surrounding the exporting of controlled substances to laws enhancing incentives for the development of treatments for rare diseases. Previous experience includes serving as the chief economist at Bloomberg Government where he built and led a team of over 30 analysts that studied the impact of government actions on the business. Also, as the economist for the Biotechnology Industry Organization, he researched, wrote on, and developed policy proposals on topics including intellectual property, comparative effectiveness, and biosimilars.
This person is not in any offices
Braeburn
Braeburn is dedicated to delivering solutions for people living with the serious consequences of opioid use disorder. They are committed to advancing next-generation therapies, with individualized dosing regimens and delivery options, to address the escalating disease burden of opioid use disorder faced by patients, healthcare professionals, payers and society.